CD2 and acute myeloid leukemia: This pattern also occurs with the general T cell markers such as CD3D, CD3E, CD2 and most markers of naive T-cell, effector memory T-cell, effector T-cell and natural killer cells, such as LEF1 which has been proven to be a predictor of better treatment response in AML.